| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 96.549 | 91.594 | 91.970 | 98.492 | 86.896 | 87.716 | 93.092 | 99.327 | 109.256 | 103.287 |
| Total Income - EUR | 96.549 | 91.594 | 91.975 | 98.495 | 86.901 | 87.721 | 93.106 | 99.332 | 109.308 | 103.292 |
| Total Expenses - EUR | 87.593 | 80.947 | 84.337 | 89.407 | 82.477 | 82.118 | 85.131 | 91.255 | 100.401 | 99.234 |
| Gross Profit/Loss - EUR | 8.956 | 10.647 | 7.638 | 9.088 | 4.424 | 5.603 | 7.975 | 8.077 | 8.907 | 4.058 |
| Net Profit/Loss - EUR | 7.523 | 8.782 | 6.698 | 8.091 | 3.553 | 5.036 | 7.186 | 7.097 | 7.828 | 2.356 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Farmasim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 737 | 729 | 510 | 332 | 144 | 0 | 410 | 278 | 158 | 0 |
| Current Assets | 26.006 | 27.408 | 25.927 | 26.415 | 20.294 | 24.060 | 21.739 | 23.456 | 28.733 | 25.480 |
| Inventories | 4.670 | 8.199 | 10.482 | 10.173 | 8.467 | 9.256 | 8.298 | 5.935 | 7.905 | 11.496 |
| Receivables | 6.604 | 3.805 | 9.981 | 10.707 | 7.485 | 8.732 | 8.749 | 9.008 | 11.061 | 6.359 |
| Cash | 14.733 | 15.404 | 5.464 | 5.535 | 4.342 | 6.072 | 4.692 | 8.514 | 9.767 | 7.625 |
| Shareholders Funds | 10.292 | 11.523 | 9.393 | 10.736 | 6.147 | 7.581 | 9.674 | 9.593 | 10.317 | 12.614 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 16.450 | 16.614 | 17.045 | 16.011 | 14.291 | 16.479 | 12.475 | 14.142 | 18.575 | 12.865 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmasim S.r.l.